Dr. Stuart Paul Feldman, MD

Dr. Feldman practices at Westmed Medical Group in Purchase, New York.

Dr. Feldman's NPI, 1376529586, was assigned on December 20, 2005. Dr. Feldman graduated from George Washington University School of Medicine and Health Sciences in 1977. Dr. Feldman's New York license number on file is 134891.

Dr. Feldman's primary practice is Westmed Medical Group, at 3030 Westchester Ave, Purchase, NY 10577 in Westchester County. The practice phone is (908) 988-0428.

Dr. Feldman's primary practice is Westmed Medical Group in Purchase, New York. The medical group on file is Westmed Medical Group. Dmand AI also links Dr. Feldman to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feldman practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Feldman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Feldman is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Feldman's licenses on file in 2 states: New York and Connecticut.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Feldman treats.

CMS data shows 11,456 Medicare services from Dr. Feldman across 24 procedure codes in 2024, for 369 Medicare patients. Medicare paid $148,003 for them.

CMS counts 369 Medicare patients who saw Dr. Feldman in 2024. The largest group is 75 to 84, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feldman's median patient age at 66, with 66% women.

In 2024, Dr. Feldman wrote 850 Medicare Part D claims for 223 patients. 62% of them were for generic drugs. CMS names the drug for 771 of them, across 19 drugs with 11 or more claims each, at $2,975,675 in total drug cost. In 2023, CMS named 652 claims across 13 drugs.

Dr. Feldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feldman as offering telehealth.

Dmand AI links 3 papers to Dr. Feldman in 2023. 2023 was the busiest year, with 2. Dr. Feldman's most frequent co-author is Melanie Moses, MD.

CMS Open Payments shows 21 general payments to Dr. Feldman from 9 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 62% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,714.

Dmand AI lists 3 awards for Dr. Feldman, most recently Westchester Magazine: Top Doctors in 2017. Dr. Feldman serves on Empire State Hematology Oncology Society.

Dr. Feldman graduated from George Washington University School of Medicine and Health Sciences in 1977. Dr. Feldman is a member of ASCO and ASH.

Dr. Feldman is in network with 18 carriers, including Elevance, Aetna and MVP Health Care. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.